Your Complete UK Wegovy Supply Solution Awaits
Complete Wegovy Dosage Chart with Reliable UK Stock
Understanding the Wegovy dosage chart is essential for successful weight management, and having reliable UK stock availability makes all the difference. Our comprehensive Wegovy dosage chart covers the complete 20-week escalation protocol, starting with 0.25mg for weeks 1-4, progressing through 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), before reaching the 2.4mg maintenance dose from week 17 onwards. Unlike many UK suppliers who face chronic Wegovy shortages, EverydayMeds maintains consistent stock levels across all five doses through our direct partnership with Novo Nordisk.
The importance of following the exact Wegovy dosage chart cannot be overstated - this prescription-only medicine requires careful dose escalation to minimise side effects whilst maximising effectiveness. Each dose serves a specific purpose in your weight management journey, with the initial 0.25mg helping your body adjust to semaglutide, whilst the final 2.4mg maintenance dose provides optimal appetite control. Our UK stock availability means you'll never face treatment interruptions due to supply issues, ensuring your progress remains consistent throughout the entire dosage schedule.
Wegovy Dosage Chart Pricing and Value Bundles
Our transparent Wegovy dosage chart pricing eliminates surprises, with single pens ranging from £79.99 for the 0.25mg starter dose to £209.99 for the 2.4mg maintenance pen. New customers can apply discount code FIRST40 at checkout, whilst returning patients benefit from code DOSE25 to reach these final prices. Our Getting Started bundles prove particularly popular - the Intro Duo (0.25mg & 0.5mg) costs £169.99, providing your first 8 weeks of treatment in one convenient order. For those following the complete Wegovy dosage chart progression, our Intro Trio bundle includes 0.25mg, 0.5mg, and 1mg pens for £299.99.
Bundle pricing reflects convenience rather than savings - fewer orders, Reliable Supply continuity, and single delivery logistics. The Progress Trio (0.5mg, 1mg & 1.7mg) at £369.99 covers weeks 5-16 of your dosage chart journey, whilst our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99. All pricing includes our 3-minute clinical assessment, prescriber review by our GPhC-registered team (#9012878), and next-day temperature-controlled delivery once approved.
Clinical Evidence Supporting the Wegovy Dosage Chart Protocol
The specific Wegovy dosage chart protocol stems from extensive clinical research, particularly the STEP trial programme published by Wilding et al. in the New England Journal of Medicine, 2021. In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks using this exact dose escalation schedule. The gradual progression from 0.25mg to 2.4mg allows patients to adapt to semaglutide's effects whilst building towards the therapeutic maintenance dose.
The STEP 5 trial demonstrated that patients maintaining the full 2.4mg Wegovy dosage chart schedule achieved sustained 15.2% weight reduction at two years. SELECT cardiovascular outcomes research showed a 20% reduction in major cardiovascular events amongst patients following the complete dosage protocol. This evidence supports the importance of adhering to the prescribed Wegovy dosage chart rather than attempting shortcuts or dose modifications.
How Wegovy Works Throughout the Dosage Chart Progression
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to support weight management alongside a reduced-calorie diet and increased physical activity. As you progress through the Wegovy dosage chart, increasing semaglutide levels work on your brain's appetite centres to reduce food cravings and promote feelings of fullness after smaller meals. The gradual dose escalation allows your digestive system to adapt whilst building therapeutic semaglutide levels. Each weekly injection using the FlexTouch pen delivers consistent medication levels, with higher doses providing enhanced appetite control. By the time you reach the 2.4mg maintenance dose, Wegovy's full weight management benefits are typically established, supporting long-term healthy eating patterns and portion control.
Streamlined UK Ordering Process for Your Wegovy Dosage Chart
Securing your complete Wegovy dosage chart supply through EverydayMeds takes just minutes, starting with our 3-minute online clinical assessment covering your weight management history and current health status. Our UK-registered prescribers review your information within 3 working days (or 24 hours with express service), ensuring Wegovy suits your individual circumstances before approving your prescription-only medicine. Once approved, your chosen doses ship via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements throughout transit. Our GPhC-registered pharmacy (#9012878) handles all aspects of your Wegovy supply, from clinical assessment through to doorstep delivery. You'll receive tracking information and storage guidance with every order, ensuring your Wegovy dosage chart progression continues smoothly.
Wegovy Dosage Chart Storage and Practical Considerations
Proper storage ensures your Wegovy dosage chart medication remains effective throughout treatment, with unused pens requiring refrigeration at 2-8°C until first use. Once removed from the fridge, Wegovy pens maintain potency for up to 6 weeks at room temperature below 30°C, offering excellent travel flexibility compared to alternatives. Each FlexTouch pen contains four doses of your prescribed strength, with clear dose escalation instructions provided with every delivery. The mandatory progression through each Wegovy dosage chart stage cannot be skipped - moving too quickly between doses may increase side effects without improving outcomes. Weekly injection timing should remain consistent, with most patients choosing the same day each week for their Wegovy dose. Never share FlexTouch pens between patients, and always use a new needle for each injection to maintain sterility and dosing accuracy.
UK Stock Availability Advantage for Wegovy Dosage Chart Compliance
Consistent stock availability directly impacts Wegovy dosage chart success, as treatment interruptions can compromise your weight management progress and potentially require dose re-escalation. Our UK inventory management system monitors stock levels across all five Wegovy doses, with automatic reordering triggered well before supplies run low. While other UK pharmacies frequently face Wegovy shortages lasting weeks or months, our direct Novo Nordisk partnership ensures continuous availability for both new and existing patients.
Treatment continuity proves especially crucial during dose transitions - running out of 0.5mg when you're ready to progress to 1mg can delay your entire Wegovy dosage chart schedule. Our bundle options eliminate this risk by providing multiple doses in single orders, whilst our subscription service can automatically deliver your next dose before your current supply expires. This stock reliability means you can focus on your weight management journey rather than worrying about medication availability.
Complete Your Wegovy Dosage Chart Journey with Confidence
Starting your Wegovy dosage chart progression with Reliable UK supply removes the uncertainty that affects many weight management journeys across Britain. Apply discount code FIRST40 if you're a new customer, or DOSE25 for returning patients, then complete our clinical assessment to begin your prescription review process. Our complete range of single pens and convenient bundles ensures you can structure your Wegovy supply according to your preferences and budget. Visit https://everydaymeds.co.uk/collections/wegovy to explore our full Wegovy range and begin your clinically-supported weight management journey. With next-day delivery, comprehensive dosage guidance, and ongoing clinical support, EverydayMeds provides everything needed for successful Wegovy treatment outcomes.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
